222 related articles for article (PubMed ID: 12043310)
41. Hyperandrogenism in a postmenopausal woman presenting with a metastatic ileum endocrine tumor.
Bachelot A; Meduri G; Baudin E; Kuttenn F; Touraine P
Fertil Steril; 2004 Mar; 81(3):675-8. PubMed ID: 15037419
[TBL] [Abstract][Full Text] [Related]
42. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
43. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
44. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
45. Hypothyroidism and hyperlipidemia with a virilizing ovarian steroid cell tumor, not otherwise specified.
Tsai HJ; Chen SC; Wei HY; Chen GD
Gynecol Endocrinol; 2007 Feb; 23(2):69-71. PubMed ID: 17454154
[TBL] [Abstract][Full Text] [Related]
46. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
[TBL] [Abstract][Full Text] [Related]
47. Polycystic ovary syndrome after menopause: a case report.
Pauli S; Lobo RA
J Reprod Med; 2004 Jun; 49(6):491-4. PubMed ID: 15283061
[TBL] [Abstract][Full Text] [Related]
48. Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature.
Sachdeva P; Arora R; Dubey C; Sukhija A; Daga M; Singh DK
Gynecol Endocrinol; 2008 Apr; 24(4):230-4. PubMed ID: 18382911
[TBL] [Abstract][Full Text] [Related]
49. An unusual circulating steroid profile in a virilized postmenopausal woman.
Benavent Correro P; Sáenz Valls M; García Cano A; Jiménez Mendiguchia L; Moreno Moreno E; Luque-Ramírez M
Diagnosis (Berl); 2018 Jun; 5(2):83-87. PubMed ID: 29752879
[TBL] [Abstract][Full Text] [Related]
50. [Hyperandrogenic syndrome in a postmenopausal woman: a case report].
Polisseni F; Gonçalves Júnior H; Vidal VR; Macedo FL; Lins BD; Campos JD; Mattos NA
Rev Bras Ginecol Obstet; 2011 Aug; 33(8):214-20. PubMed ID: 22159623
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
52. Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman.
Pinto AM; Martins MB; Oliveira N; Oliveira M
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444026
[TBL] [Abstract][Full Text] [Related]
53. Ovarian dysgerminoma associated with Pseudo-Meigs' syndrome and functioning ovarian stroma: a case report.
Gücer F; Oz-Puyan F; Mülayim N; Yüce MA
Gynecol Oncol; 2005 May; 97(2):681-4. PubMed ID: 15863182
[TBL] [Abstract][Full Text] [Related]
54. Hilus cell tumour of the ovary in a virilized, premenopausal woman. Case report and review of hyperandrogenism of ovarian origin.
Moore A; Permezel M; Mulvany N; Pepperell RJ
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):75-8. PubMed ID: 10099755
[TBL] [Abstract][Full Text] [Related]
55. The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin.
Vaikkakara S; Al-Ozairi E; Lim E; Advani A; Ball SG; James RA; Quinton R
Gynecol Endocrinol; 2008 Feb; 24(2):87-92. PubMed ID: 18210332
[TBL] [Abstract][Full Text] [Related]
56. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
57. A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism.
Kozan P; Chalasani S; Handelsman DJ; Pike AH; Crawford BA
J Clin Endocrinol Metab; 2014 Jan; 99(1):12-7. PubMed ID: 24152686
[TBL] [Abstract][Full Text] [Related]
58. Leydig cell tumor in the post-menopausal woman: case report and literature review.
Sherf S; Martinez D
Acta Biomed; 2016 Jan; 87(3):310-313. PubMed ID: 28112699
[TBL] [Abstract][Full Text] [Related]
59. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman.
Souto SB; Baptista PV; Barreto F; Sousa PF; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2012 Dec; 56(9):672-6. PubMed ID: 23329192
[TBL] [Abstract][Full Text] [Related]
60. A case report of steroid cell tumour of the ovary--not otherwise specified variant with hyperandrogenism, hypercortisolism, hyperprolactinemia and hyperestrogenemia.
Abebe S; Erkie M; Feleke Y
Ethiop Med J; 2010 Jan; 48(1):67-72. PubMed ID: 20608001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
